You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 2, February 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Expression of ICAM-1 in Nasal Epithelium and Levels of Soluble ICAM-1 in Nasal Lavage Fluid During Human Experimental Rhinovirus Infection

Birgit Winther, MD; Eurico Arruda, MD, PhD; Theodore J. Witek, DrPH; Steven D. Marlin, PhD; Michael M. Tsianco, PhD; Donald J. Innes, MD; Frederick G. Hayden, MD

Arch Otolaryngol Head Neck Surg. 2002;128:131-136.

Most rhinovirus serotypes use intercellular adhesion molecule-1 (ICAM-1) as the receptor to enter cells, but ICAM-1 expression has not been detected on normal nasal epithelial cells. During experimental rhinovirus infection, expression of ICAM-1 on nasal epithelial cells was examined with immunohistochemical staining of nasal scrape biopsy specimens, and levels of soluble ICAM-1 in nasal lavage fluid were measured by sandwich enzyme-linked immunosorbent assay technique. Expression of ICAM-1 on nasal epithelial cells increased following inoculation in 20 of 23 infected subjects. The median number of ICAM-1–positive cells per 6.25-mm2 area of stained biopsy specimen was 0 in control samples (day 20 or 33 after inoculation), and in those without infection, 6 on day 1 (P<=.05), 14.5 on day 3 (P<=.01), 1.5 on day 5, and 0 on day 9. In a different group of volunteers, soluble ICAM-1 in nasal lavage fluid was higher on days 1 and 3 compared with preinoculation levels (P<=.001), but only 11 of 23 infected subjects had a 2-fold or greater increase. Up-regulation of ICAM-1 receptor expression on nasal epithelial cells occurred within 24 hours after inoculation in experimental rhinovirus infections (prior to onset of symptoms) and declined promptly by day 5.


From the Departments of Otolaryngology and Pediatrics (Dr Winther), Internal Medicine (Drs Arruda and Hayden), and Pathology (Drs Arruda, Innes, and Hayden), University of Virginia School of Medicine, Charlottesville; and Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Conn (Drs Witek, Marlin, and Tsianco). Dr Arruda is now with the University of Sào Paulo School of Medicine, Department of Parasitology, Microbiology and Immunology, Ribeirao Preto, São Paulo, Brazil.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Host defense function of the airway epithelium in health and disease: clinical background
Message and Johnston
J. Leukoc. Biol. 2004;75:5-17.
ABSTRACT | FULL TEXT  

Human Rhinovirus Selectively Modulates Membranous and Soluble Forms of Its Intercellular Adhesion Molecule-1 (ICAM-1) Receptor to Promote Epithelial Cell Infectivity
Whiteman et al.
J. Biol. Chem. 2003;278:11954-11961.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.